Fresenius Medical Care AG & Co. (Pref) (ETR:FME) has been given a €93.00 ($109.41) target price by equities research analysts at Nord/LB in a note issued to investors on Thursday. The firm currently has a “buy” rating on the stock.

A number of other equities analysts also recently weighed in on the stock. Goldman Sachs Group, Inc. (The) set a €98.00 ($115.29) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research note on Monday, July 24th. Oddo Securities set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research note on Thursday, July 20th. S&P Global set a €95.00 ($111.76) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research note on Tuesday, August 1st. Berenberg Bank set a €92.10 ($108.35) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research note on Tuesday, August 1st. Finally, J P Morgan Chase & Co set a €106.40 ($125.18) target price on shares of Fresenius Medical Care AG & Co. (Pref) and gave the stock a “buy” rating in a research note on Thursday, July 27th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of €89.12 ($104.84).

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/02/nordlb-analysts-give-fresenius-medical-care-ag-93-00-price-target.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.